Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 14, 2020 - Issue
Submit an article Journal homepage
125
Views
10
CrossRef citations to date
0
Altmetric
Original Research

The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells

Zhenyu Wang1 School of Radiation Medicine and Protection (SRMP) of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4132-4699
ORCID Icon,
Wenhao Shen1 School of Radiation Medicine and Protection (SRMP) of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, People’s Republic of China
,
Xugang Li2 Department of Radiotherapy, Anshan Cancer Hospital, Anshan 114036, People’s Republic of China
,
Yang Feng1 School of Radiation Medicine and Protection (SRMP) of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, People’s Republic of China
,
Kun Qian1 School of Radiation Medicine and Protection (SRMP) of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, People’s Republic of China
,
Gaoren Wang3 Nantong Tumor Hospital, Affiliated Tumor Hospital of Nantong University, Nantong 226361, People’s Republic of China
,
Yiying Gao1 School of Radiation Medicine and Protection (SRMP) of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-1061-1326
ORCID Icon,
Xiaohui Xu4 Department of General Surgery, The First People’s Hospital of Taicang, Taicang Affiliated Hospital of Soochow University, Suzhou 215400, People’s Republic of China
,
Shuyu Zhang1 School of Radiation Medicine and Protection (SRMP) of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, People’s Republic of China
,
Ling Yue1 School of Radiation Medicine and Protection (SRMP) of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, People’s Republic of China
&
Jianping Cao1 School of Radiation Medicine and Protection (SRMP) of Soochow University, State Key Laboratory of Radiation Medicine and Protection, Suzhou 215123, People’s Republic of ChinaCorrespondence[email protected] [email protected]
 show all
Pages 3099-3110 | Published online: 31 Jul 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Song Yang, Gaohua Han, Quan Chen, Lei Yu, Peng Wang, Qi Zhang, Jiang Dong, Wei Zhang & Junxing Huang. (2021) Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects. International Journal of Nanomedicine 16, pages 239-248.
Read now

Articles from other publishers (9)

Mingjun Chen, Huijie Wang, Qian Cui, Juanjuan Shi & Yongzhong Hou. (2024) Dual function of activated PPARγ by ligands on tumor growth and immunotherapy. Medical Oncology 41:5.
Crossref
Hongtao Duan, Li Gao, Aiminuer Asikaer, Lingzhi Liu, Kuilong Huang & Yan Shen. (2024) Prognostic Model Construction of Disulfidptosis-Related Genes and Targeted Anticancer Drug Research in Pancreatic Cancer. Molecular Biotechnology.
Crossref
Yunkuo Li, Yujie Pan, Xiaodong Zhao, Shouwang Wu, Faping Li, Yuxiong Wang, Bin Liu, Yanghe Zhang, Xin Gao, Yishu Wang & Honglan Zhou. (2024) Peroxisome proliferator-activated receptors: A key link between lipid metabolism and cancer progression. Clinical Nutrition 43:2, pages 332-345.
Crossref
Jisha Pillai U, Anindita Ray, Meenu Maan & Mainak Dutta. (2023) Repurposing drugs targeting metabolic diseases for cancer therapeutics. Drug Discovery Today 28:9, pages 103684.
Crossref
Paulina Nowak, Iwona Bil-Lula & Mariola Śliwińska-Mossoń. (2023) A Cross-Talk about Radioresistance in Lung Cancer—How to Improve Radiosensitivity According to Chinese Medicine and Medicaments That Commonly Occur in Pharmacies. International Journal of Molecular Sciences 24:13, pages 11206.
Crossref
Chuanzhong Huang, Ling Wang, Huijing Chen, Wankai Fu, Lingdong Shao, Dongmei Zhou, Junxin Wu & Yunbin Ye. (2023) A positive feedback loop between ID3 and PPARγ via DNA damage repair regulates the efficacy of radiotherapy for rectal cancer. BMC Cancer 23:1.
Crossref
Angèle Luby & Marie-Clotilde Alves-Guerra. (2022) UCP2 as a Cancer Target through Energy Metabolism and Oxidative Stress Control. International Journal of Molecular Sciences 23:23, pages 15077.
Crossref
Yi Pan, Junyang Li, Susu Lou, Wanbiao Chen, Yihang Lin, Nan Shen & Youjin Li. (2022) Down-Regulated miR-130a/b Attenuates Rhabdomyosarcoma Proliferation via PPARG. Frontiers in Molecular Biosciences 8.
Crossref
Tianxing Zhou, Jing Liu, Yongjie Xie, Shuai Yuan, Yu Guo, Weiwei Bai, Kaili Zhao, Wenna Jiang, Hongwei Wang, Haotian Wang, Tiansuo Zhao, Chongbiao Huang, Song Gao, Xiuchao Wang, Shengyu Yang & Jihui Hao. (2022) ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. Gut 71:2, pages 357-371.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.